This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
HIV patients with CD4 counts less than 200 who received pneumocystis jiroveci pneumonia (PCP) prophylaxis
The HIV Research Network.
1.59 HIV patients age 18 and over with CD4 cell count less than 200 who received PCP prophylaxis, by race, United States, 2002.
HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).
Patients diagnosed with HIV with CD4 counts < 200 cells/mm.
Subset of denominator who received PCP prophylactic therapy.
The taxonomy of the PCP organism has been changed; Pneumocystis jiroveci refers to the distinct species that infects humans. The abbreviation PCP is still used to designate Pneumocystis pneumonia.
For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC website at http://www.cdc.gov/mmwr/.